Celebrating International Women’s Day

Learn more about a few of our featured female scientists Today, March 8, 2020, marks International Women’s Day. ZEISS Research Microscopy applauds the many women scientists across the globe who are driving research forward. Read a few examples of women scientists profiled on our blog and how their efforts are contributing to advancement of many... Read more

Sale of EMS Brüel & Kjær completed

28 February 2020 – Further to the announcement on 17 January, Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces that it has completed the sale of its interest in the EMS Brüel & Kjær joint venture to Envirosuite Limited. Contacts: Spectris plcSiobhán AndrewsHead of Corporate Affairs +44 1784 485325... Read more

2019 full year results

20 February 2020 – Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, announces full year results for the twelve months ended 31 December 2019. Executing our Strategy for Profitable Growth – Sales of £1,632.0 million, reflecting a 0.4% LFL sales increase – Adjusted operating profit increased 3.7%, on a LFL basis,... Read more

QIAGEN’s QuantiFERON®-TB Gold Plus to be adopted for latent TB testing in Nigeria

Hilden, Germany, and Germantown, Maryland, February 20, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Nigeria, the country with the largest population in Africa and one of the world’s 30 high-disease burden countries for tuberculosis (TB), has published guidelines recommending QuantiFERON®-TB Gold Plus (QFT®-Plus) in screening for latent TB infection (LTBI)... Read more

China National Medical Products Administration grants approval of Roche’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer

This marks the first approval for a Tecentriq-based therapy in China, less than a year after the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals in this indication Tecentriq with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy combination approved for the initial treatment of extensive-stage small cell... Read more

Investigating the Link between Influenza Virus and Bacterial Infections

Researchers at St. Jude Children’s Research Hospital utilize superresolution technology  Single S. pneumonia bacterium (green) with multiple influenza virions (red) all over the surface On a recent cover of Nature Microbiology, you will find superresolution microscopy images captured by the laboratory of Dr. Jason Rosch at St. Jude Children’s Research Hospital, Memphis, USA. These images,... Read more

Xylem to host its 2020 Investor and Analyst Day

RYE BROOK, N.Y.–(BUSINESS WIRE)–Feb. 4, 2020– Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, will host its 2020 Investor and Analyst Day on Tuesday, March 31, in Atlanta, GA, at the Company’s Data Analytics & Software Center of Excellence. Xylem President and Chief Executive... Read more

Roche reports very strong results in 2019

Basel, 30 January 2020 Group sales increase 9%1 at constant exchange rates and 8% in Swiss francs, driven by new products, more than compensating for impact of competition from biosimilars Pharmaceuticals Division sales up 11%, resulting from high demand for recently launched medicines, led by Ocrevus, Hemlibra, Tecentriq and Perjeta Diagnostics Division sales grow by... Read more

Material Characterization in Additive Manufacturing

From powder to reliable parts: a webinar highlighting light microscopy solutions Additive manufacturing is one of the top trends in academic research and industry. Its unique benefits include: New design possibilities – providing engineers with the freedom to innovate as well as light weight construction New materials – including high temperature resistance and improved mechanical... Read more

JEOL Ltd. Acquires IDES

Acquisition of INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC. 2020/01/17 JEOL Ltd. (headquartered in Akishima, Tokyo; JEOL hereafter) acquired all shares of INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC. (headquartered in California, USA; IDES hereafter), an entrepreneurial venture specialized in technologies related to transmission electron microscopy (TEM hereafter), and made IDES its wholly-owned subsidiary. Background and Objective JEOL is... Read more